期刊文献+

HPLC法测定复方酮替芬滴鼻液中3组分的含量 被引量:1

Content Determination of Three Main Drugs in Compound Ketotifen Fumarate Nasal Drops by HPLC
下载PDF
导出
摘要 目的:测定复方酮替芬滴鼻剂中主要成分的含量。方法:采用HPLC法,色谱柱Diamonsil C18柱(4.6mm×150mm,5μm);流动相为乙腈-1%乙酸胺溶液(pH5.5)=10∶90;流速为1mL·min-1;检测波长为240nm;柱温为室温。结果:富马酸酮替芬在40.0~160.0μg·mL-1的范围内,其浓度与峰面积呈良好的线性关系,得回归方程A=1.178C-5.193,r=0.9995(n=7),平均回收率为100.61%,RSD=0.49%(n=5)。盐酸麻黄碱在200.0~800.0μg·mL-1的范围内,其浓度与峰面积呈良好的线性关系,得回归方程A=0.3680C-6.455,r=0.9993(n=7),平均回收率为99.99%,RSD=0.38%(n=5)。呋喃西林在8.0~30.0μg·mL-1的范围内,其浓度与峰面积呈良好的线性关系,得回归方程A=66.58x-4.103,C=0.9998(n=7),呋喃西林的平均回收率为98.69%,RSD=0.92%(n=5)。结论:本方法建立的高效液相色谱法操作简单,准确、专属性强、重现性好,可作为复方酮替芬滴鼻剂中酮替芬、麻黄碱、呋喃西林的含量测定。 Objective: To determine the contents of main drugs in compound ketotifen fumarate nasal drops. Methods: An HPLC method was employed with the chromatographic column as Diamonsil C18 (4.6mm×150mm, 5μm, room temperature). The mobile phase was acetonitrile: ammonium acetate(pH 5.5)= 10:90. The flow rate was 1.0 mL·min^-1. The detection wavelength was 240 nm. Results: Ketotifen fumarate has a good linearity over the range of 40.0-160.0 μg·mL^-1, with the regression equation of A=1.178C-5.193, r=0.9995(n=7). The average recovery rate was 100.61%, RSD was 0.49%(n=5). Ephedrine hydrochloride has a good linearity at the range of 200.0-800.0 μg·mL^-1, with the regression equation of A=0.3680C-6.455, r= 0.9993 (n=7). The average recovery rate was 99.99%, RSD was 0.38%(n=5). Nitrofurazone has a good linearity over the range of 8.0-30.0 μg·mL^-1, with the regression equation of A=66.58C-4.103, r=0.99987 (n=7). The average recovery rate was 98.69%, RSD was 0.92%(n=5). Conclusion: The proposed method is simple, specific, and can be used in the content determination of ketotifen fumarate, ephedrine hydrochloride and nitrofurazone in compound Ketotifen fumarate nasal drops.
出处 《药学与临床研究》 2010年第1期56-58,共3页 Pharmaceutical and Clinical Research
关键词 复方酮替芬 滴鼻剂 高效液相色谱 含量测定 Compound ketotifen fumarate nasal drops HPLC Content determination
  • 相关文献

参考文献2

二级参考文献4

  • 1吴明钗,胡瑞颖,谢兵.酮替芬麻黄碱喷鼻剂的制备及质量控制[J].西北药学杂志,2005,20(6):260-262. 被引量:2
  • 2.中国医院制剂规范西药制剂[M]·第2版[M].北京:中国医药科技出版社,1995.165.
  • 3梅丹,徐君,李大魁.抗变态反应药物.见:陈新谦,金有豫,汤光主编.新编药物学.第15版.北京:人民卫生出版社,2003.549-551
  • 4高长凤.眼用制剂附加剂见:实用药物制剂技术[M].北京:人民卫生出版社,1999:333-334

共引文献3

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部